Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated alpha-synuclein. Prasinezumab has the potential for Parkinsons disease research.
Purity:
>99.0%
CAS Number:
[1960462-19-4]
* VAT and and shipping costs not included. Errors and price changes excepted